Informa plc has appointed Adam Andersen Group Director of the Pharma Portfolio (previously part of UBM), which includes ...
Thermo Fisher Scientific, the world leader in serving science, and Symphogen, a clinical-stage antibody oncology-focused...
Singapore – The FDA grants 510(k) clearance for Bio-Rad Laboratories' IH-Reader 24, a semi-automated blo...
Singapore – Aimed at satisfying European Commission (EC) concerns about the potential overlap in the inflammatory ...
EBD Group (EBD), the market-leading provider of world-class partnering events and tools for the global life science...
Elpis Biomed Ltd. (Elpis), a University of Cambridge spin-out developing high quality human cells via its proprietary OP...
M3 Biotechnology, a Seattle-based therapeutics company dedicated to developing, first-in-class, therapies for Alzhe...
ICON plc, (NASDAQ: ICLR) a global provider of drug development services to the pharmaceutical, biotechnology and me...
Bain Capital and Pfizer have announced the creation of Cerevel Therapeutics, a new biopharmaceutical company...
AstraZeneca, and its global biologics research and development arm MedImmune, have announced a new multi-term agreement ...
Singapore – A non-opioid drug developed by Pfizer and Eli Lilly met the main go...
Synthego, a leading genome engineering innovation company, today announced a $110 million Series C financing round led b...
Kibow Biotech is proud to announce its 21st year of operations as a pioneer with the use of Pro/Prebiotics in people wit...
Congenica, the global diagnostic decision support platform provider, announced a key partnership with the UK’s&nbs...
Stream Bio Ltd, a company that develops and manufactures a range of revolutionary bioimaging molecular probes, is expand...
AstraZeneca and Merck have announced detailed results from the Phase III SOLO-1 trial testing Lynparza (...
Singapore - The FDA approves Regeneron Pharmaceuticals and development partner Sanofi's DUPIXENT (dupilumab) a...
Singapore - Results from a Phase 3 clinical trial, IMpassion130, evaluating Roche unit Genentech's TECENTRIQ (...